Bath & Body Works, Inc. (NYSE:BBWI) Shares Acquired by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC increased its position in Bath & Body Works, Inc. (NYSE:BBWI) by 109.7% in the fourth quarter, Holdings Channel reports. The firm owned 1,629 shares of the company’s stock after purchasing an additional 852 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Bath & Body Works were worth $63,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. FMR LLC lifted its holdings in Bath & Body Works by 17,496.5% in the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after acquiring an additional 2,501,828 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in Bath & Body Works by 13.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,704,625 shares of the company’s stock worth $66,088,000 after acquiring an additional 195,813 shares during the last quarter. Erste Asset Management GmbH bought a new position in Bath & Body Works in the third quarter worth about $50,483,000. Forest Avenue Capital Management LP lifted its holdings in Bath & Body Works by 19.1% in the third quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock worth $46,851,000 after acquiring an additional 235,173 shares during the last quarter. Finally, Verition Fund Management LLC lifted its holdings in Bath & Body Works by 111.8% in the third quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company’s stock worth $42,957,000 after acquiring an additional 710,333 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Performance

Bath & Body Works stock opened at $30.24 on Thursday. The firm has a market cap of $6.55 billion, a price-to-earnings ratio of 7.37, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. Bath & Body Works, Inc. has a 1 year low of $26.21 and a 1 year high of $52.99. The firm’s 50 day moving average price is $35.96 and its two-hundred day moving average price is $33.96.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. As a group, equities analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date of this dividend was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.65%. Bath & Body Works’s dividend payout ratio (DPR) is 21.98%.

Bath & Body Works declared that its board has initiated a stock buyback program on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on BBWI shares. Deutsche Bank Aktiengesellschaft raised their target price on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. JPMorgan Chase & Co. set a $47.00 price target on Bath & Body Works in a report on Thursday, February 27th. Robert W. Baird lifted their price target on Bath & Body Works from $45.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 28th. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. Finally, Raymond James reaffirmed an “outperform” rating and set a $46.00 price target (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. Five research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $45.06.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.